Testing effectiveness (Phase 2)Study completedNCT01026493
What this trial is testing
Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma
Who this might be right for
Brain and Central Nervous System Tumors
Radiation Therapy Oncology Group 257